Karina Bienfait

1.6k total citations
17 papers, 1.1k citations indexed

About

Karina Bienfait is a scholar working on Neurology, Cognitive Neuroscience and Pharmacology. According to data from OpenAlex, Karina Bienfait has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 7 papers in Cognitive Neuroscience and 3 papers in Pharmacology. Recurrent topics in Karina Bienfait's work include Parkinson's Disease Mechanisms and Treatments (11 papers), Autism Spectrum Disorder Research (5 papers) and Neurological disorders and treatments (4 papers). Karina Bienfait is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (11 papers), Autism Spectrum Disorder Research (5 papers) and Neurological disorders and treatments (4 papers). Karina Bienfait collaborates with scholars based in United States, Belgium and Netherlands. Karina Bienfait's co-authors include Matthew Menza, Roseanne D. Dobkin, Michael A. Gara, Humberto Marín, Allison Dicke, Margery H. Mark, Steven Buyske, Lesley A. Allen, Jill Harkavy‐Friedman and M. H. Mark and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Karina Bienfait

17 papers receiving 1.1k citations

Peers

Countries citing papers authored by Karina Bienfait

Since Specialization

Citations

This map shows the geographic impact of Karina Bienfait's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karina Bienfait with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karina Bienfait more than expected).

Fields of papers citing papers by Karina Bienfait

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karina Bienfait. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karina Bienfait. The network helps show where Karina Bienfait may publish in the future.

Co-authorship network of co-authors of Karina Bienfait

This figure shows the co-authorship network connecting the top 25 collaborators of Karina Bienfait. A scholar is included among the top collaborators of Karina Bienfait based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karina Bienfait. Karina Bienfait is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG) 2021 ·Human Genetics ·Karina Bienfait, Aparna Chhibber, Jean‐Claude Marshall, Martin Armstrong, Charles Cox, Peter Shaw, Charles Paulding	20
2	Mobilizing Pharmacogenomic Analyses During Clinical Trials in Drug Development 2013 ·Pharmacogenomics ·Karina Bienfait, Peter Shaw, (unknown), Amelia Warner	4
3	Improving Clinical Trial Sampling for Future Research – an International Approach: Outcomes and Next Steps from the DIA Future Use Sampling Workshop 2011 2012 ·Pharmacogenomics ·Amelia Warner, Karina Bienfait, Marianna J. Bledsoe, Gilbert J. Burckart, Bruno Flamion, Bartha Maria Knoppers, Anita J. Nelsen, (unknown), (unknown), Yoshiaki Uyama	3
4	Challenges in Obtaining Adequate Genetic Sample Sets in Clinical Trials: The Perspective of the Industry Pharmacogenomics Working Group 2011 ·Clinical Pharmacology & Therapeutics ·Amelia Warner, Anahita Bhathena, (unknown), (unknown), Diane U. Leong, Karina Bienfait, (unknown), (unknown), (unknown), Andrew C. Nelsen, Amir Snapir	15
5	Telephone-Based Cognitive–Behavioral Therapy for Depression in Parkinson Disease 2011 ·Journal of Geriatric Psychiatry and Neurology ·Roseanne D. Dobkin, Matthew Menza, Lesley A. Allen, (unknown), Jill Harkavy‐Friedman, Karina Bienfait, Michael A. Gara, Margery H. Mark	65
6	Cognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial 2011 ·American Journal of Psychiatry ·Roseanne D. Dobkin, Matthew Menza, Lesley A. Allen, Michael A. Gara, Margery H. Mark, (unknown), Karina Bienfait, Jill Harkavy‐Friedman	212
7	The Impact of Antidepressant Treatment on Cognitive Functioning in Depressed Patients with Parkinson’s Disease 2010 ·Journal of Neuropsychiatry ·Roseanne D. Dobkin, Matthew Menza, Karina Bienfait, Michael A. Gara, Humberto Marín, Margery H. Mark, Allison Dicke, Alexander I. Tröster	27
8	Impulsive smoking in a patient with Parkinson’s disease treated with dopamine agonists 2010 ·Journal of Clinical Neuroscience ·Karina Bienfait, Matthew Menza, Margery H. Mark, Roseanne D. Dobkin	21
9	Treatment of insomnia in Parkinson's disease: A controlled trial of eszopiclone and placebo 2010 ·Movement Disorders ·Matthew Menza, Roseanne D. Dobkin, Humberto Marín, Michael A. Gara, Karina Bienfait, Allison Dicke, Cynthia L. Comella, Charles R. Cantor, Lee Hyer	73
10	Depression in Parkinson's Disease: Symptom Improvement and Residual Symptoms After Acute Pharmacologic Management 2010 ·American Journal of Geriatric Psychiatry ·Roseanne D. Dobkin, Matthew Menza, Karina Bienfait, Michael A. Gara, Humberto Marín, Margery H. Mark, Allison Dicke, Jill Harkavy‐Friedman	29
11	Sleep disturbances in Parkinson's disease 2010 ·Movement Disorders ·Matthew Menza, Roseanne D. Dobkin, Humberto Marín, Karina Bienfait	113
12	The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson’s Disease 2010 ·Psychosomatics ·Matthew Menza, Roseanne D. Dobkin, Humberto Marín, Margery H. Mark, Michael A. Gara, Karina Bienfait, Allison Dicke, (unknown)	139
13	Ramelteon for the treatment of insomnia in menopausal women 2009 ·Menopause international ·Roseanne D. Dobkin, Matthew Menza, Karina Bienfait, Lesley A. Allen, Humberto Marín, Michael A. Gara	25
14	The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease 2009 ·Movement Disorders ·Matthew Menza, Roseanne D. Dobkin, Humberto Marín, Margery H. Mark, Michael A. Gara, Steven Buyske, Karina Bienfait, Allison Dicke	67
15	Escitalopram Reduces Hot Flashes in Nondepressed Menopausal Women: A Pilot Study 2009 ·Annals of Clinical Psychiatry ·Roseanne D. Dobkin, Matthew Menza, Lesley A. Allen, Humberto Marín, Karina Bienfait, (unknown), (unknown)	17
16	A controlled trial of antidepressants in patients with Parkinson disease and depression 2008 ·Neurology ·Matthew Menza, Roseanne D. Dobkin, Humberto Marín, M. H. Mark, Michael A. Gara, Steven Buyske, Karina Bienfait, Allison Dicke	277
17	CBT for the treatment of depression in Parkinson’s disease: a promising nonpharmacological approach 2007 ·Expert Review of Neurotherapeutics ·Roseanne D. Dobkin, Matthew Menza, Karina Bienfait	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact